Sameer Ashok Parikh
Impact in
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 181
- Chronic Lymphocytic Leukemia Research 179
-
- Lymphoma Diagnosis and Treatment 100
- Co-authors
- Tait D. Shanafelt (65 shared papers)Neil E. Kay (92 shared papers)Timothy G. Call (72 shared papers)Susan L. Slager (71 shared papers)Wei Ding (66 shared papers)Jose Francisco Leis (50 shared papers)Susan Marie Schwager (40 shared papers)Curtis A. Hanson (34 shared papers)
- Journals
- Blood (60 papers)American Journal of Hematology (19 papers)Blood Cancer Journal (19 papers)Leukemia (15 papers)Haematologica (10 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Sameer Ashok Parikh
216 papers receiving 6.5k citations
Sameer Ashok Parikh's Hit Papers
Peers
Comparison fields: 5 of 101
- Genetics 4.2k
- Pathology and Forensic Medicine 2.8k
- Hematology 1.3k
- Immunology 1.8k
- Oncology 1.3k
Countries citing papers authored by Sameer Ashok Parikh
This map shows the geographic impact of Sameer Ashok Parikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer Ashok Parikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer Ashok Parikh more than expected).
Fields of papers citing papers by Sameer Ashok Parikh
This network shows the impact of papers produced by Sameer Ashok Parikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer Ashok Parikh. The network helps show where Sameer Ashok Parikh may publish in the future.
Co-authors
The 25 scholars most cited alongside Sameer Ashok Parikh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 234 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL Hit paper breakdown → | 2018 | 747 |
| 2 | Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms Hit paper breakdown → | 2015 | 412 |
| 3 | 2017 | 362 | |
| 4 | 2014 | 255 | |
| 5 | 2016 | 199 | |
| 6 | 2013 | 194 | |
| 7 | 2017 | 174 | |
| 8 | 2014 | 150 | |
| 9 | 2019 | 128 | |
| 10 | 2022 | 120 | |
| 11 | 2016 | 115 | |
| 12 | 2019 | 104 | |
| 13 | 2020 | 100 | |
| 14 | 2015 | 90 | |
| 15 | 2015 | 88 | |
| 16 | 2015 | 88 | |
| 17 | 2017 | 80 | |
| 18 | 2010 | 80 | |
| 19 | 2014 | 75 | |
| 20 | 2015 | 69 |
About Sameer Ashok Parikh
Sameer Ashok Parikh is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Hematology and Oncology, having authored 234 papers that have together received 6.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (179 papers), Lymphoma Diagnosis and Treatment (100 papers), Immunodeficiency and Autoimmune Disorders (53 papers), Advanced Breast Cancer Therapies (18 papers), CAR-T cell therapy research (16 papers), Gastrointestinal Tumor Research and Treatment (14 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Acute Lymphoblastic Leukemia research (11 papers). The work is most often cited by research in Genetics (4.2k citations), Pathology and Forensic Medicine (2.8k citations), Hematology (1.3k citations), Immunology (1.8k citations) and Oncology (1.3k citations). Sameer Ashok Parikh has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Tait D. Shanafelt, Neil E. Kay, Timothy G. Call, Susan L. Slager, Wei Ding, Jose Francisco Leis, Susan Marie Schwager, Curtis A. Hanson, Kari G. Rabe and Kari G. Chaffee. Their work appears in journals such as Blood, American Journal of Hematology, Blood Cancer Journal, Leukemia and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.